Introduction On 15 May 2026, the National Medical Products Administration (NMPA) officially promulgated the Implementation Measures for Protection of Drug Trial Data (the Implementation Measures) via Announcement No. 47 of 2026, which took effect on the s...

In November 2025, China issued a revised version of its Patent Examination Guidelines, which took effect on January 1 2026. The revision introduces significant changes to the examination standards for patent applications in the field of biological breedin...

In recent years, China has emerged as a significant global player in the pharmaceutical sector, not only due to its vast market potential but also because of its evolving intellectual property (IP) framework. To further encourage innovation in life scienc...

A Practice Note addressing the final remedies available in patent infringement litigation under the laws of China. This Note is part of a global suite of jurisdiction-specific resources helping in-house lawyers and private practice attorneys navigate eac...